Publique en esta revista
Información de la revista
Vol. 2. Núm. S1.
I Simposio de Dolor en Reumatología
Páginas S55-S66 (Marzo 2006)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. S1.
I Simposio de Dolor en Reumatología
Páginas S55-S66 (Marzo 2006)
I Simposio de Dolor en Reumatología
DOI: 10.1016/S1699-258X(06)73084-4
Acceso a texto completo
Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia
Visitas
...
J. Riveraa, C. Alegreb,??
Autor para correspondencia
calegre@vhebron.net

Correspondencia: Dr. C. Alegre de Miquel. Escuela de Enfermería. Hospital Universitario Vall d’Hebron. Pg. Vall d’Hebron, 129, 5.ª planta. 08035 Barcelona. España.
, F.J. Ballinac, J. Carbonelld, L. Carmonae, B. Castelf, A. Colladog, J.J. Esteveh, F.G. Martínezi, J. Torneroj, M.A. Vallejok, J. Vidalj
a Coordinador del documento de consenso. Unidad de Reumatología. Instituto Provincial de Rehabilitación. Hospital Gregorio Marañón. Madrid. España
b Coordinador del documento de consenso. Unidad de Reumatología. Servicio de Medicina Interna. Hospital Universitario Vall d’Hebron. Barcelona. España
c Miembro del panel de expertos. Sección de Reumatología. Hospital Universitario Central de Asturias. Oviedo. Asturias. España
d Miembro del panel de expertos. Servicio de Reumatología IMAS. Hospital de l’Esperança y Hospital del Mar. Barcelona. España
e Miembro del panel de expertos. Unidad de Investigación. Fundación Española de Reumatología. Madrid. España
f Miembro del panel de expertos. Servicio de Psiquiatría. Hospital Universitario de Guadalajara. Guadalajara. España
g Miembro del panel de expertos. Servicio de Reumatología. Hospital Clínico y Provincial. Barcelona. España
h Miembro del panel de expertos. Reumatología. Hospital General Universitario de Alicante. Alicante. España
i Miembro del panel de expertos. Reumatología. Hospital Universitario Reina Sofía. Córdoba. España
j Miembro del panel de expertos. Sección de Reumatología. Hospital Universitario de Guadalajara. Guadalajara. España
k Miembro del panel de expertos. Facultad de Psicología. UNED. Madrid. España
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Fibromyalgia: the Copenhagen declaration.
Lancet, 340 (1992), pp. 663-664
[2.]
F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, et al.
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia.
Arthritis Rheum, 33 (1990), pp. 160-172
[3.]
Sociedad Española de Reumatología. Estudio EPISER. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española. Madrid: Sociedad Española de Reumatología; 2001.
[4.]
L. Carmona, F.J. Ballina, R. Gabriel, A. Laffon, EPISER Study Group.
The burden of musculoskeletal diseases in the general population of Spain: results from a nation-wide study.
Ann Rheum Dis, 60 (2001), pp. 1040-1045
[5.]
G. Reid, A. Lang, P. Mcgrath.
Primary juvenile fibromyalgia.
[6.]
F. Wolfe, K. Ross, J. Anderson, I.J. Russell, L. Hebert.
The prevalence and characteristics of fibromyalgia in the general population.
Arthritis Rheum, 38 (1995), pp. 19-28
[7.]
Fundación Grünenthal, Sociedad Española de Reumatología.
Estudio EPIDOR: estudio epidemiológico del dolor en España.
Edipharma, (2003),
[8.]
L.M. Arnold, J.I. Hudson, E.V. Hess, A.E. Ware, D.A. Fritz, M.B. Auchenbach, et al.
Family study of fibromyalgia.
Arthritis Rheum, 50 (2004), pp. 944-952
[9.]
D. Buskila, L. Neumann, I. Hazanov, R. Carmi.
Familial aggregation in the fibromyalgia syndrome.
Semin Arthritis Rheum, 26 (1996), pp. 605-611
[10.]
S. Gursoy, E. Erdal, H. Herken, E. Madenci, B. Alasehirli, N. Erdal.
Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.
Rheumatol Int, 23 (2003), pp. 104-107
[11.]
M. Offenbaecher, B. Bondy, S. De Jonge, K. Glatzeder, M. Krüger, P. Schoeps, et al.
Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region.
[12.]
R.T. Goldberg, W.N. Pachas, D. Keith.
Relationship between traumatic events in childhood and chronic pain.
Disabil Rehabil, 21 (1999), pp. 23-30
[13.]
K. Imbierowicz, U.T. Egle.
Childhood adversities in patients with fibromyalgia and somatoform pain disorder.
Eur J Pain, 7 (2003), pp. 113-119
[14.]
S.A. Epstein, G. Kay, D. Clauw, R. Heaton, D. Klein, L. Krupp, et al.
Psychiatric disorders in patients with fibromyalgia: A multicenter investigation.
Psychosom Med, 40 (1999), pp. 57-63
[15.]
K. Thieme, D.C. Turk, H. Flor.
Comorbid depression and anxiety in fibromyalgia syndrome: relationships to somatic and psychosocial variables.
Psychosom Med, 66 (2004), pp. 837-844
[16.]
U.M. Anderberg, T. Forsgren, L. Ekselius, I. Marteinsdottir, J. Hallman.
Personality traits on the basis of the temperament and character inventory in female fibromyalgia syndrome patients.
Nord J Psychiatry, 53 (1999), pp. 353-359
[17.]
M.J.M. Villagran, C.M. Paez, G.F. Campo, V. Verez, M.J. Salaberro.
Psychopathology and fibromyalgia.
Arq Psiquiatr, 63 (2000), pp. 159-181
[18.]
L.J. Crofford.
The relationship of fibromyalgia to neuropathic pain syndromes.
J Rheumatol Suppl, 75 (2005), pp. 41-45
[19.]
M. Kivimäki, P. Leino-Arjas, M. Virtanen, M. Elovainio, L. Keltikangas-Järvinen, S. Puttonen, et al.
Work stress and incidence of newly diagnosed fibromyalgia prospective cohort study.
J Psychosom Res, 57 (2004), pp. 417-422
[20.]
S.M. Campbell, S. Clark, E.A. Tindall, M.E. Forehand, R.M. Bennett.
Clinical characteristics of fibrositis: A “blinded” controlled study of symptoms and tender points.
Arthritis Rheum, 26 (1983), pp. 817-824
[21.]
C. Arenas Cabrera, J. Bautista Lorite.
Estudios neuromusculares en la fibromialgia.
Rev Esp Reumatol, 27 (2000), pp. 430-435
[22.]
L.J. Crofford, M.A. Demitrack.
Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome.
Rheum Dis Clin North Am, 22 (1996), pp. 267-284
[23.]
M. Martínez-Lavín, A.G. Hermosillo.
Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia.
Semin Arthritis Rheum, 29 (2000), pp. 197-199
[24.]
L.E. Blanco, F.J. De Serres, E. Fernández-Bustillo, D.A. Kassam, D. Arbesu, C. Rodríguez, et al.
Alpha1-antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia.
Med Hypotheses, 64 (2005), pp. 759-769
[25.]
D.D. Price, R. Staud.
Neurobiology of fibromyalgia syndrome.
J Rheumatol Suppl, 75 (2005), pp. 22-28
[26.]
J.D. Kranzler, J.F. Gendreau, S.G. Rao.
The psychopharmacology of fibromyalgia: a drug development perspective.
Psychopharmacol Bull, 36 (2002), pp. 165-213
[27.]
R.H. Gracely, F. Petzke, J.M. Wolf, D.J. Clauw.
Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.
Arthritis Rheum, 46 (2002), pp. 1333-1343
[28.]
I.J. Russell.
The promise of substance P inhibitors in fibromyalgia.
Rheum Dis Clin North Am, 28 (2002), pp. 329-342
[29.]
M.B. Yunus, A.T. Masi, J.J. Calabro, K.A. Miller, S.L. Feigenbaum.
Primary fibromyalgia (fibrositis): a clinical study of 50 patients with matched controls.
Sem Arthritis Rheum, 11 (1981), pp. 151-171
[30.]
F. Leavitt, R.S. Katz, H.E. Golden.
Comparison of pain propierties in fibromyalgia patients and rheumatoid arthritis patients.
Arthritis Rheum, 29 (1986), pp. 775-781
[31.]
P.A. Reilly, G.O. Littlejohn.
Peripheral arthralgic presentation of fibrositis/ fibromialgia syndrome.
J Rheumatol, 19 (1992), pp. 281-283
[32.]
F. Wolfe, D.J. Hawley, K. Wilson.
The prevalence and meaning of fatigue in rheumatic disaese.
J Rheumatol, 23 (1996), pp. 1407-1417
[33.]
K. Fukuda, S.E. Strauss, I. Hickie, M.C. Sharpe, J.G. Dobbins, A. Komarofff, For the Chronic Fatigue Syndrome Group.
Chronic fatigue syndrome: a comprehensive approach to its definition and study.
Ann Intern Med, 121 (1994), pp. 953-959
[34.]
P. Jennun, A.M. Drewes, A. Andreasen, K.D. Nielsen.
Sleep and other symptoms in primary fibromyalgia and in healthy controls.
J Rheumatol, 20 (1993), pp. 1756-1759
[35.]
R.W. Simms, D.L. Goldenberg.
Symptoms mimicking neurologic disorders in fibromialgia syndrome.
J Rheumatol, 15 (1988), pp. 1271-1273
[36.]
J. Albornoz, J. Povedano, J. Quijada, J.L. De la Iglesia, A. Fernández, D. Pérez-Vílchez, et al.
Características clínicas y sociolaborales de la fibromialgia en España: descripción de 193 pacientes.
Rev Esp Reumatol, 24 (1997), pp. 38-44
[37.]
M.B. Yunus, J.C. Aldag.
Restless legs syndrome and leg cramps in fibromyalgia syndrome. A controlled study.
BMJ, 312 (1996), pp. 1339
[38.]
H. Cohen, L. Newman, M. Shore, M. Amir, Y. Cassuto, D. Buskila.
Autonomic disfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability.
Sem Arthritis Rheum, 29 (2000), pp. 217-227
[39.]
B. Dick, C. Eccleston, G. Crombez.
Attentional functioning in fibromyalgia, rheumatoid arthritis and musculoskeletal pain patients.
Arthritis Rheum, 47 (2002), pp. 639-644
[40.]
D.C. Park, J.M. Glass, M. Minear, L.J. Crofford.
Cognitive function in fibromyalgia patients.
[41.]
A. Cott, W. Parkinson, M. Bell, J. Adachi, M. Bedard, A. Cividino, et al.
Interrater reliability of the tender points criterion for fibromyalgia.
J Rheumatol, 19 (1992), pp. 1955-1959
[42.]
F. Wolfe, K. Michaud.
Severe rheumatoid arthritis, worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia.
J Rheumatol, 31 (2004), pp. 695-700
[43.]
E. Chamizo.
¿Existe asociación entre la fibromialgia y el aumento de la comorbilidad: enfermedad neoplásica, cardiovascular e infecciones y de la mortalidad?.
Reumatol Clin, 1 (2005), pp. 200-210
[44.]
C. Nimnuan, M. Hotopf, S. Wessely.
Medically unexplained symptoms: an epidemilogical study in seven specialties.
J Psychosom Res, 51 (2001), pp. 361-367
[45.]
E.A. Malt, J.E. Berle, S. Olafsson, A. Lund, H. Ursin.
Fibromyalgia is associated with panic disorder and functional dyspepsia with mood disorders. A study of women with random sample population controls.
J Psychosom Res, 49 (2000), pp. 285-289
[46.]
H. Cohen, L. Neumann, Y. Haiman, M.A. Matar, J. Press, D. Buskila.
Prevalence of post-traumatic stress disorders in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome?.
Semin Arthritis Rheum, 32 (2002), pp. 38-50
[47.]
R.A. Sansone, P. Whitecar, B. Meier, A. Murry.
The prevalence of borderline personality among primary care patients with chronic pain.
Gen Hosp Psychiatry, 23 (2001), pp. 193-197
[48.]
J. Ledingham, S. Doherty, M. Doherty.
Primary fibromyalgia syndrome- an outcome study.
Br J Rheumatol, 32 (1993), pp. 139-142
[49.]
M. Kennedy, D.T. Felson.
A prospective long-term study of fibromyalgia syndrome.
Arthritis Rheum, 39 (1996), pp. 682-685
[50.]
G. Granges, P. Zilko, G.O. Littlejohn.
Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis.
J Rheumatol, 21 (1994), pp. 523-529
[51.]
R. Poyhia, D. Da Costa, M.A. Fitzcharles.
Pain and pain relief in fibromyalgia patients followed for three years.
[52.]
D.L. Goldenberg, C.J. Mossey, C.H. Schmid.
A model to assess severity and impact of fibromyalgia.
J Rheumatol, 22 (1995), pp. 2313-2318
[53.]
J.E. Martínez, I.S. Barauna Filho, K. Kubokawa, I.S. Pedreira, L.A. Machado, G. Cevasco.
Evaluation of the quality of life in Brazilian women with fibromyalgia, through the medical outcome survey 36 item short-form study.
Disabil Rehabil, 23 (2001), pp. 64-68
[54.]
A.L. Bernard, A. Prince, P. Edsall.
Quality of life issues for fibromyalgia patients.
Arthritis Care Res, 13 (2000), pp. 42-50
[55.]
S. Reisine, J. Fifield, S.J. Walsh, R. Feinn.
Do employment and family work affect the health status of women with fibromyalgia?.
J Rheumatol, 30 (2003), pp. 2045-2053
[56.]
J.E. Martínez, M.B. Ferraz, E.I. Sato, E. Atra.
Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life.
J Rheumatol, 22 (1995), pp. 270-274
[57.]
C.S. Burckhardt, S.R. Clark, R.M. Bennett.
Fibromyalgia and quality of life: a comparative analysis.
J Rheumatol, 20 (1993), pp. 475-479
[58.]
M. Paulson, A. Norberg, S. Soderberg.
Living in the shadow of fibromyalgic pain: the meaning of female partners’ experiences.
J Clin Nurs, 12 (2003), pp. 235-243
[59.]
L. Neumann, D. Buskila.
Quality of life and physical functioning of relatives of fibromyalgia patients.
Semin Arthritis Rheum, 26 (1997), pp. 834-839
[60.]
R.M. Bennett.
Fibromyalgia disability: appearence versus reality [editorial].
J Rheumatol, 11 (1993), pp. 1829
[61.]
J. Rivera.
Controversias en el diagnóstico de fibromialgia.
Rev Esp Reumatol, 3 (2004), pp. 501-506
[62.]
F. Wolfe, J. Anderson, D. Harkness, X.J. Caro, D.L. Goldenberg, I.J. Russell, et al.
Work and disability status of persons with fibromyalgia.
J Rheumatol, 24 (1997), pp. 1171-1178
[63.]
J. Tornero, J. Vidal.
Impacto social y económico de las enfermedades reumáticas: la discapacidad laboral.
Rev Esp Reumatol, 26 (1999), pp. 347-366
[64.]
F. Wolfe, J. Anderson, D. Harkness, R.M. Bennett, X.J. Caro, D.L. Goldenberg, et al.
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia.
[65.]
R.L. Robinson, H.G. Birnbaum, M.A. Morley, T. Sisitsky, P.E. Greenberg, A.J. Claxton.
Economic cost and epidemiological characteristics of patients with fibromialgia claims.
J Rheumatol, 30 (2003), pp. 1318-1325
[66.]
K.P. White, M. Speechley, M. Harth, T. Østbye.
The London fibromyalgia epidemiology study: direct health care cost of fibromyalgia syndrome in London, Canada.
J Rheumatol, 26 (1999), pp. 885-889
[67.]
A. Boonen, R. Van der Heuvel, A. Van Tubergen, M. Goossens, J.L. Severens, D. Van der Heijde, et al.
Large differences in cost of illness and wellbeing between patients with fybromyalgia, chronic low back pain, or ankylosing spondylitis.
Ann Rheum Dis, (2005), pp. 396-402
[68.]
Carmona L. ¿El diagnóstico en sí de fibromialgia tiene algún efecto deletéreo sobre el pronóstico? Revisión sistemática de la SER, 2005. Reumatol Clin. 2006 [En prensa].
[69.]
K.P. White, W.R. Nielson, M. Harth, T. Ostbye, M. Speechley.
Does the label “Fibromyalgia” alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain.
Arthritis Care Res, 47 (2002), pp. 260-265
[70.]
M. Bosi Ferraz, M.R. Quaresma, L.R. Aquino, E. Atra, P. Tugwell, C.H. Goldsmith.
Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis.
J Rheumatol, 17 (1990), pp. 1022-1024
[71.]
R. Melzack.
The McGill Pain Questionnaire: major properties and scoring methods.
Pain, 1 (1975), pp. 277-299
[72.]
R. Ruiz López, M. Pagerols Bonilla, I. Ferrer Marrades, A. Collado Cruz.
El lenguaje del dolor.
Med Clin (Barc), 96 (1991), pp. 196
[73.]
R.D. Kerns, D.C. Turk, T.E. Rudy.
The West Haven-Yale Multidimensional Pain Inventory (WHYMPI).
Pain, 23 (1985), pp. 345-356
[74.]
D.C. Turk, A. Okifuji, J.D. Sinclair, T.W. Starz.
Pain, disability, and physical functioning in subgroups of patients with fibromyalgia.
J Rheumatol, 23 (1996), pp. 1255-1262
[75.]
X. Badia, C. Muriel, A. Gracia, J.M. Núñez-Olarte, N. Perulero, R. Gálvez, et al.
Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica.
Med Clin (Barc), 120 (2003), pp. 52-59
[76.]
J. Rivera Redondo, C. Moratalla Justo, F. Valdepeñas Moraleda, Y. García Velayos, J.J. Osés Puche, J. Ruiz Zubero, et al.
Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach.
Arthritis Rheum, 51 (2004), pp. 184-192
[77.]
P.G. O’Malley, E. Balden, G. Tomkins, J. Santoro, K. Kroenke, J.L. Jackson.
Treatment of fibromyalgia with antidepressants: A meta-analysis.
J Gen Intern Med, 15 (2000), pp. 659-666
[78.]
C.S. Burckhardt, S.R. Clark, R.M. Bennett.
The Fibromyalgia Impact Questionnaire: Development and validation.
J Rheumatol, 18 (1991), pp. 728-733
[79.]
J. Rivera, T. González.
The Fibromyalgia Impact Questionnaire: A validated Spanish version to assess the health status in women with fibromyalgia.
Clin Exp Rheumatol, 22 (2004), pp. 554-560
[80.]
Esteve-Vives J, Batlle-Gualda E. Evaluación de pacientes con fibromialgia: estudio comparativo de cuatro versiones españolas del Cuestionario de Impacto de la Fibromialgia (FIQ). 2006. [En prensa].
[81.]
J.E. Ware, C.D. Sherbourne.
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
Med Care, 30 (1992), pp. 473-483
[82.]
J. Alonso, L. Prieto, J.M. Antó.
La versión española del SF-36 Health Survey (Cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos.
Med Clin (Barc), 104 (1995), pp. 771-776
[83.]
J.F. Fries.
The assessment of disability: from first to future principles.
Br J Rheumatol, 22 (1983), pp. 48-58
[84.]
J. Esteve-Vives, E. Batlle Gualda, A. Reig.
Grupo para la Adaptación del HAQ a la población Española. Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency.
J Rheumatol, 20 (1993), pp. 2116-2122
[85.]
F. Wolfe, D.J. Hawley, D.L. Goldenberg, I.J. Russell, D. Buskila, L. Neumann.
The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire.
J Rheumatol, 27 (2000), pp. 1989-1999
[86.]
D.P. Goldberg, V.F. Hillier.
A scaled version of the General Health Questionnaire.
Psychol Med, 9 (1979), pp. 139-145
[87.]
L.R. Derogatis.
SCL-90 Manual.
Johns Hopkins University School of Medicine, (1977),
[88.]
W.G. Dahlstrom, G.S. Welsh, L.E. Dahlstrom.
University of Minnesota Press, (1972),
[89.]
A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, J. Erbaugh.
An inventory for measuring depression.
Arch Gen Psychiatry, 4 (1961), pp. 561-571
[90.]
L.S. Radloff.
The CES-D Scale: a self-report depression scale for research in the general population.
App Psychol Meas, 1 (1977), pp. 385-401
[91.]
E.R. Serber, T.A. Cronan, H.R. Walen.
Predictors of patient satisfaction and health care cost for patients with fibromyalgia.
Psychol Health, 18 (2003), pp. 771-787
[92.]
C. Spielberger, R. Gorsuch, R. Lushene.
Manual for the sate-trait anxiety inventory.
Consulting Psychology Press, (1970),
[93.]
A.S. Zigmond, R.P. Snaith.
The Hospital Anxiety and Depression Scale.
Acta Psy Scan, 67 (1983), pp. 361-370
[94.]
M.P. Jensen, J.A. Turner, J.M. Romano, S.E. Strom.
The Chronic Pain Coping Inventory: development and preliminary validation.
Pain, 60 (1995), pp. 203-216
[95.]
K. Lorig, R.L. Chastain, E. Ung, S. Shoor, H.R. Holman.
Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis.
Arthritis Rheum, 32 (1989), pp. 37-44
[96.]
V.M. González, A. Stewart, P.L. Ritter, K. Lorig.
Translation and validation of arthritis outcome measures into Spanish.
Arthritis Rheum, 38 (1995), pp. 1429-1446
[97.]
K.O. Anderson, B.N. Dowds, R.E. Pelletz, W.T. Edwards, C. Peeters-Asdourian.
Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain.
Pain, 63 (1995), pp. 77-84
[98.]
S.E. Gowans, A. De Hueck, S. Voss, A. Silaj, S.E. Abbey.
Six-month and one-year follow-up of 23 weeks of aerobic exercise for individuals with fibromyalgia.
Arthritis Rheum, 51 (2004), pp. 890-898
[99.]
Nishishinya B. ¿Existen instrumentos capaces de discriminar a pacientes con dolor crónico y fibromialgia respecto a pronóstico y/o respuesta clínica? Revisión sistemática de la SER, 2005. Reumatol Clin. 2006 [En prensa].
[100.]
C. Alegre, C.A. Pereda, B. Nishishinya, J. Rivera.
Revisión sistemática de las intervenciones farmacológicas en la fibromialgia.
Med Clin (Barc), 125 (2005), pp. 784-787
[101.]
L.A. Rossy, S.P. Buckelew, N. Dorr, K.J. Hagglund, J.F. Thayer, M.J. McIntosh, et al.
A meta-analysis of fibromyalgia treatment interventions.
Ann Behav Med, 21 (1999), pp. 180-191
[102.]
L.M. Arnold, P.E. Keck Jr, J.A. Welge.
Antidepressant treatment of fibromyalgia. A meta-analisis and review.
Psychosomatics, 41 (2000), pp. 104-113
[103.]
S.G. Rao.
The neuropharmacology of centrally-acting analgesic medications in fibromyalgia.
Rheum Dis Clin North Am, 28 (2002), pp. 235-259
[104.]
O. Vitton, M. Gendreu, J. Kranzler, G. Rao.
A double blind placebo-controlled trial of minalcipram in the treatment of fibromyalgia.
Hum Psychopharmacol Clin Exp, 19 (2004), pp. 27-35
[105.]
L.M. Arnold, Y. Lu, L.J. Crofford, M. Wohlreich, M.J. Detke, S. Iyengar, et al.
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arthritis Rheum, 50 (2004), pp. 2974-2984
[106.]
L.J. Crofford, M.C. Rowbotham, P.J. Mease, I.J. Russell, R.H. Dworkin, A.E. Corbin, et al.
Pregabalin for the treatment of fibromyalgia syndrome. Results of a randomized double blind placebo controlled trial.
Arthritis Rheum, 52 (2005), pp. 1264-1273
[107.]
A. Busch, C.L. Schachter, P.M. Peloso, C. Bombardier.
Exercise for treating fibromyalgia síndrome [Cochrane Review].
The Cochrane Library, issue 1, Update Software, (2003),
[108.]
Nishishinya MB, Rivera J, Alegre de Miquel C, Pereda CA, Carbonell Abelló J. Revisión sistemática de las intervenciones no farmacológicas y alternativas en la fibromialgia. 2006 [En prensa].
[109.]
D.H. Barlow, J. Lawton, A.E. Vitali.
Psychosocial treatments for panic disorders, phobias, and generalized anxiety disorders.
A guide to treatments that work, pp. 288-388
[110.]
M.I. Díaz, M.I. Comeche, M.A. Vallejo.
Guía de tratamientos psicológicos eficaces en el dolor crónico.
Guía de tratamientos psicológicos eficaces II. Psicología de la salud, pp. 123-140
[111.]
F.J. Keefe, D.S. Caldwell.
Cognitive behavioural control of arthritis pain.
Med Clin North Am, 81 (1998), pp. 277-290
[112.]
C. Wells-Federman, P. Arnstein, M. Caudill-Slosberg.
Comparing patients with fibromyalgia and chronic low back pain participating in an outpatient cognitive-behavioral treatment program.
J Musculoskeletal Pain, 11 (2003), pp. 5-12
[113.]
D.A. Williams.
Psychological and behavioural therapies in fibromyalgia and related syndromes.
Best Pract Res Clin Rheumatol, 17 (2003), pp. 649-665
[114.]
V.A. Hadhazy, J. Ezzo, P. Creamer, B.M. Berman.
Mind-body therapy for the treatment of fibromyalgia. A systematic review.
J Rheumatol, 27 (2000), pp. 2911-2918
[115.]
S.P. Buckelew, R. Conway, J. Parker, W.E. Deuser, J. Read, T.E. Witty, et al.
Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial.
Arthritis Care Res, 11 (1998), pp. 196-209
[116.]
C.S. Burckhardt, K. Mannerkorpi, L. Hedenberg, A. Bjelle.
A randomized, controlled clinical trial of education and physical training for women with fibromyalgia.
J Rheumatol, 21 (1994), pp. 714-720
[117.]
A. Collado Cruz, X. Torresi Mata, A. Arias i Gassol, D. Cerdà Garbaroi, R. Vilarrasa, M. Valdés Miyar, et al.
Eficacia del tratamiento multidisciplinario del dolor crónico incapacitante del aparato locomotor.
Med Clin (Barc), 117 (2001), pp. 401-405
[118.]
K. Karjalainen, A. Malmivaara, M. Van Tulder, R. Roine, M. Jauhiainen, H. Hurri, et al.
Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults [Cochrane Review].
The Cochrane Library, Issue 4, John Wiley & Sons, (2003),
[119.]
J. Sim, N. Adams.
Systematic review of randomized controlled trials of nonpharmacological interventions for fibromyalgia.
Clin J Pain, 18 (2002), pp. 324-336
[120.]
I.R. Bell, D.A. Lewis 2nd, A.J. Brooks, G.E. Schwartz, S.E. Lewis, B.T. Walsh, et al.
Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo.
Rheumatology (Oxford), 43 (2004), pp. 577-582
[121.]
T. Field, M. Diego, C. Cullen, M. Hernández-Rif, W. Sunshine, S. Douglas.
Fibromyalgia pain and substance P decrease and sleep improves after massage therapy.
J Clin Rheumatol, 8 (2002), pp. 72-76
[122.]
Carmona L. ¿El pronóstico de la fibromialgia es mejor o peor si el seguimiento lo realiza un reumatólogo? Revisión sistemática de la SER, 2005. Reumatol Clin. 2006 [En prensa].
[123.]
M.A. Fitzcharles, P. Boulos.
Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals.
Rheumatology (Oxford), 42 (2003), pp. 263-267
Copyright © 2006. Elsevier España S.L. Barcelona
Idiomas
Reumatología Clínica

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.